Results 131 to 140 of about 36,968 (256)

Strategies to prevent excessive red blood cells during platelet-rich plasma collection in patients with elevated hematocrit

Zhongguo shuxue zazhi
[Objective] For patients with elevated hematocrit (Hct), platelet-rich plasma (PRP) apheresis is prone to red blood cell contamination—commonly referred to as “flushing” or erythrocyte carryover—which compromises product quality and therapeutic efficacy.
YANG Lijuan, TAN Qiang, WU Ling, PENG Tao, GAN Xinyu, REN Lina, MA Xin   +6 more
doaj   +1 more source

Bacterial screening of platelet donations in England, 2014–2023

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Bacterial contamination of blood components is an ongoing problem in transfusion medicine. We analysed the bacterial screening data of platelets from England, 2014–2023, and compared this with data on reported near‐misses and transfusion‐transmitted infections (TTIs). Materials and Methods Anonymized data on bacterial
Vidushi Chugh, Shannah Secret, Katy Davison, Autumn St John, Peter Simmonds, Susan R. Brailsford, Heli Harvala   +6 more
wiley   +1 more source

Bridging the attitude–behaviour gap in blood donation: A large‐scale knowledge–attitudes–practices study among university students in China

Vox Sanguinis, EarlyView.
Abstract Background and Objectives University students are a vital yet underutilized donor population, constrained by a knowledge–attitude–practice (KAP) gap. We sought to assess the KAP status and identify modifiable determinants of blood donation among university students in a major Chinese city to inform targeted recruitment strategies.
Li Zhao, Jianhuai Jin, Jiali Yao, Ling Chen   +3 more
wiley   +1 more source

Adjunctive Therapeutic Plasma Exchange in Refractory Adult‐Onset Still's Disease Complicated by Secondary Macrophage Activation Syndrome: A Single‐Center Experience

Therapeutic Apheresis and Dialysis, Volume 30, Issue 3, Page 389-396, June 2026.
ABSTRACT Introduction Adult‐onset Still's disease (AOSD) complicated by macrophage activation syndrome (MAS) carries substantial mortality. The role of therapeutic plasma exchange (TPE) remains uncertain. Methods We retrospectively analyzed patients with AOSD‐MAS treated with TPE at a single‐center.
Masataka Ueda, Tomohiro Saito, Masahide Mizobuchi, Tomoki Shimomura, Saki Kawamori, Mitsuru Kawanishi, Natsuko Hattori, Jo Sugiyama, Satoshi Tsubata, Hanami Horiguchi, Kazuki Abe, Nao Iida, Yuki Kajio, Nao Oguro, Ryo Yanai, Hirokazu Honda   +15 more
wiley   +1 more source

Plerixafor plus granulocyte colony-stimulating factor for patients with non-Hodgkin lymphoma and multiple myeloma: Long-term follow-up report [PDF]

, 2018
Bolwell, Brian, Cheverton, Peter D, DiPersio, John F, Horwitz, Mitchell E, Kaufman, Jonathan L, Maziarz, Richard T, McCarty, John M, Micallef, Ivana N, Nademanee, Auayporn P, Stadtmauer, Edward A, Stiff, Patrick J, Struijs, Martin, Vargo, Rita   +12 more
core   +2 more sources

A rapid and accurate approach to identify single nucleotide polymorphisms of mitochondrial DNA using MALDI-TOF mass spectrometry [PDF]

, 2017
Background: Single nucleotide polymorphisms (SNPs) of mitochondrial DNA (mtDNA) are involved in physiological and pathological conditions. We developed a rapid, accurate, highly sensitive and high-throughput approach with low cost to identify mtDNA SNPs.
Garritsen, Henk S.P., Hahn, Sinuhe, Holzgreve, Wolfgang, Morris, Michael, Tarhouny, Shereen E.L., Xiu-Cheng Fan, Alex, Zhong, Xiao Yan   +6 more
core  

Retrospective Evaluation of Dual Specialty Ports in Therapeutic Apheresis

Journal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT Dual specialty ports were evaluated for safety and efficacy in therapeutic apheresis by analyzing outcomes across 97 port placement events in 88 patients, focusing on two configurations: dual Bard PowerFlow (BP2) and a combination of Bard PowerFlow with AngioDynamics SmartPort (BP + AD).
Mugtaba Swar‐Eldahab, Barnabas Obeng‐Gyasi, Paul Haste, Matthew Krosin   +3 more
wiley   +1 more source

Pediatric Therapeutic Plasma Exchange: Characterization of Practice, Epidemiology, and Safety Profile at a Children's Hospital in the United States

Journal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT There is a need to better understand the indications and safety profiles for therapeutic plasma exchange (TPE) in children. We aimed to assess pediatric TPE practice at a large academic center by retrospective chart review from 2011 to 2022. Patient demographics and clinical information including American Society for Apheresis (ASFA) category ...
Benjamin C. Lee, Brian D. Adkins, Ayda Javanbakht, Hung S. Luu, Daniel K. Noland   +4 more
wiley   +1 more source

In vivo CAR therapies: Turning the patient into their own CAR factory

HemaSphere, Volume 10, Issue 5, May 2026.
Abstract Over the past decade, ex vivo autologous chimeric antigen receptor (CAR)‐T‐cell therapies have reshaped the treatment of B‐cell malignancies. Despite their remarkable clinical efficacy, their application remains limited by complex manufacturing processes, demanding logistics, long turnaround times, and substantial costs. In vivo CAR approaches
François Vilcot, Carole‐Anne Brugère, Jaime Fuentealba, Roch Houot   +3 more
wiley   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld, Nicole Kasatkin, Bi Liu Yu, Milen Velinov, Justin S. Brandt, Elena Ashkinadze   +5 more
wiley   +1 more source